Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A vs Ibuprofen for Sleep Bruxism and Jaw Muscle Pain
NCT07732751Phase 4Completed
- Sponsor
- Cyprus Health and Social Sciences University
- Start
- Feb 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in bruxism, myofascial pain syndrome (MPS), sponsored by Cyprus Health and Social Sciences University. Started Feb 2026; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
bruxismmyofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07732751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07732751.